Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D A Sychev

Showing results (31-40 of 83) with videos related to

Pageof 9
Sort By:
The International Journal of Risk & Safety in Medicine|December 8, 2015
VKORC1 polymorphisms and warfarin maintenance dose in population of Sakha (Yakuts)Y V Chertovskikh, E U Malova, N R Maksimova, et al.
Terapevticheskii Arkhiv|March 3, 2017
[Use of pharmacogenetic testing to prevent adverse drug reactions during statin therapy]N A Rumyantsev, V G Kukes, R E Kazakov, et al.
Voprosy Pitaniia|November 19, 2003
[Interaction of biologically active additives, containing medicinal plants with drugs]V G Kukes, E V Shikh, D A Sychev, et al.
The Application of Clinical Genetics|August 3, 2019
Pharmacogenetics of alcohol addiction: current perspectivesM S Zastrozhin, V Yu Skryabin, S S Miroshkin, et al.
Eksperimental'Naia I Klinicheskaia Gastroenterologiia = Experimental & Clinical Gastroenterology|June 12, 2018
EFFECT OF CYP2C19 GENETIC POLYMORPHISMS ON THE EFFICACY OF PROTON PUMP INHIBITOR-BASED TRIPLE ERADICATION THERAPY IN SLAVIC PATIENTS WITH PEPTIC ULCERS: A META-ANALYSISN P Denisenko, D A Sychev, Zh M Sizova, et al.
Biomeditsinskaia Khimiia|October 30, 2017
[Pharmacogenetic approaches to predicting the efficiency and safety of amlodipine in patients with arterial hypertension]D A Sychev, N V Shih, E G Kalle, et al.
The International Journal of Risk & Safety in Medicine|December 8, 2015
CYP3A4 activity and haloperidol effects in alcohol addictsM S Zastrozhin, V V Smirnov, D A Sychev, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|November 3, 2012
[Valproic acid pharmacogenetics in an individual approach to treatment of women of childbearing age with epilepsy]N A Snaĭder, D A Sychev, M S Piliugina, et al.
Terapevticheskii Arkhiv|December 21, 2020
[The pharmacogenetics of hypoglycemia and the glycemic variability at the patients ith type 2 diabetes mellitus]N A Chernikova, L L Kamynina, A S Ametov, et al.
Bulletin of Experimental Biology and Medicine|December 3, 2002
Pheno- and genotyping the prescription of drugs metabolized by CYP2D6G V Ramenskaya, A Yu Savchenko, A A Agafonov, et al.
Pageof 9

Showing results (31-40 of 83) with videos related to

Sort By:
Pageof 9
The International Journal of Risk & Safety in Medicine|December 8, 2015
VKORC1 polymorphisms and warfarin maintenance dose in population of Sakha (Yakuts)Y V Chertovskikh, E U Malova, N R Maksimova, et al.
Terapevticheskii Arkhiv|March 3, 2017
[Use of pharmacogenetic testing to prevent adverse drug reactions during statin therapy]N A Rumyantsev, V G Kukes, R E Kazakov, et al.
Voprosy Pitaniia|November 19, 2003
[Interaction of biologically active additives, containing medicinal plants with drugs]V G Kukes, E V Shikh, D A Sychev, et al.
The Application of Clinical Genetics|August 3, 2019
Pharmacogenetics of alcohol addiction: current perspectivesM S Zastrozhin, V Yu Skryabin, S S Miroshkin, et al.
Eksperimental'Naia I Klinicheskaia Gastroenterologiia = Experimental & Clinical Gastroenterology|June 12, 2018
EFFECT OF CYP2C19 GENETIC POLYMORPHISMS ON THE EFFICACY OF PROTON PUMP INHIBITOR-BASED TRIPLE ERADICATION THERAPY IN SLAVIC PATIENTS WITH PEPTIC ULCERS: A META-ANALYSISN P Denisenko, D A Sychev, Zh M Sizova, et al.
Biomeditsinskaia Khimiia|October 30, 2017
[Pharmacogenetic approaches to predicting the efficiency and safety of amlodipine in patients with arterial hypertension]D A Sychev, N V Shih, E G Kalle, et al.
The International Journal of Risk & Safety in Medicine|December 8, 2015
CYP3A4 activity and haloperidol effects in alcohol addictsM S Zastrozhin, V V Smirnov, D A Sychev, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|November 3, 2012
[Valproic acid pharmacogenetics in an individual approach to treatment of women of childbearing age with epilepsy]N A Snaĭder, D A Sychev, M S Piliugina, et al.
Terapevticheskii Arkhiv|December 21, 2020
[The pharmacogenetics of hypoglycemia and the glycemic variability at the patients ith type 2 diabetes mellitus]N A Chernikova, L L Kamynina, A S Ametov, et al.
Bulletin of Experimental Biology and Medicine|December 3, 2002
Pheno- and genotyping the prescription of drugs metabolized by CYP2D6G V Ramenskaya, A Yu Savchenko, A A Agafonov, et al.
Pageof 9